Search Site close Close
News

Clinical Study Seeks Participants with Lung Disease

Published Date:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes harder to take deep breaths. The lungs become unable to take in enough oxygen.

Dr. Rajagopal Sreedhar is recruiting participants for a clinical trial to see if pulmonary rehabilitation treatments improve the quality of life for patients with IPF. The study will compare standard of care treatment to exercise and education. The goal is test how well the combination of exercise and medication benefits the patient. All study-related visits and tests will be provided at no cost to the participant. Participants may also receive a stipend to cover travel and other related expenses.

To qualify, participants must:

  • Be 40 years of age or older
  • Have been diagnosed with IPF
  • Be currently taking the medication Ofev® (150 mg twice a day) and have taken it at a stable dose for up to 30 months

To learn more about this study, contact Abigail House, RN, at 217-545-7526.

More from SIU News

Jonas Konan, DMSc, PA-C

Jonas Gileguy Konan's journey of service, leadership and lifelong learning

Jonas Konan’s leadership path in neurosurgery and as a distinguished SIU DMSc alumnus began long before he stepped into an operating room. His commitment to patient care began as a college paramedic volunteer, on the front lines of emergency medicine in Texas.
801

Nominations and applications open for SIU School of Medicine dean, provost and CEO

Southern Illinois University School of Medicine invites nominations and applications for the position of dean, provost and CEO.
Alz research

Summer research internship opportunities at Smith Alzheimer's Center

The Smith Alzheimer’s Center at SIU Medicine is offering up to two lab internship opportunities for undergraduate college students in 2026. Selected students will explore cutting-edge research on Alzheimer’s disease.